Clinical trial
A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100 mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese
NCT00272831 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100 mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- December 31, 2007
- Enrollment
- 62 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.